Ignite Creation Date:
2025-12-24 @ 2:15 PM
Ignite Modification Date:
2025-12-29 @ 6:53 AM
Study NCT ID:
NCT01280695
Status:
COMPLETED
Last Update Posted:
2014-04-14
First Post:
2011-01-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients
Sponsor:
Metabolic Solutions Development Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-02
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-06
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-20
First Submit QC Date:
None
Study First Post Date:
2011-01-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-10-30
Results First Submit QC Date:
None
Results First Post Date:
2013-12-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-03-17
Last Update Post Date:
2014-04-14
Last Update Post Date Type:
ESTIMATED